Previous Article | Next Article 
Infect Immun, April 1998, p. 1356-1363, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Cloning and Sequencing of Three
Granulocytic Ehrlichia Genes Encoding High-Molecular-Weight
Immunoreactive Proteins
James R.
Storey,1
Linda A.
Doros-Richert,1
Cindy
Gingrich-Baker,1
Kenneth
Munroe,1
Thomas N.
Mather,2
Richard T.
Coughlin,1
Gerald A.
Beltz,1 and
Cheryl I.
Murphy1,*
Aquila Biopharmaceuticals, Inc., Worcester,
Massachusetts 01605,1 and
Center for
Vector-Borne Disease, University of Rhode Island, Kingston, Rhode
Island 028812
Received 31 October 1997/Returned for modification 8 January
1998/Accepted 27 January 1998
 |
ABSTRACT |
Granulocytic Ehrlichia was isolated from canine blood
obtained from animals challenged with field-collected Ixodes
scapularis and propagated in HL60 cells. PCR primers specific for
the 16S ribosomal DNA (rDNA) of the Ehrlichia genogroup
comprising E. equi, E. phagocytophila, and the
agent of human granulocytic ehrlichiosis (HGE) amplified DNA from
extracts of these cells. Sequence analysis of this amplified DNA
revealed that it is identical to the 16S rDNA sequence of the HGE
agent. A genomic library was constructed with DNA from granulocytic
Ehrlichia and screened with pooled sera from
tick-challenged, granulocytic Ehrlichia-infected dogs. Several clones were isolated and sequenced. Three complete genes encoding proteins with apparent molecular masses of 100, 130, and 160 kDa were found. The recombinant proteins reacted with convalescent-phase sera from dogs and human patients recovering from
HGE. This approach will be useful for identifying candidate diagnostic
and vaccine antigens for granulocytic ehrlichiosis and aid in the
classification of genogroup members.
 |
INTRODUCTION |
Members of the genus
Ehrlichia include species which have a tropism for
mononuclear phagocytes (E. canis, E. chaffeensis, E. muris, E. sennetsu, and E. risticii) (33) and those which infect granulocytes
(E. ewingii [33], E. phagocytophila [10, 33], E. equi
[14, 26], and the recently discovered agent of human
granulocytic ehrlichiosis [HGE] [3, 7]). Disease caused by granulocytic Ehrlichia (GE) is manifested by
fever, lethargy, thrombocytopenia, and death, and many species from
diverse geographical locations have shown evidence of natural
infection, including horses (25, 27, 29, 38), dogs (24,
34, 35), small mammals (39, 40), and humans (4,
15).
The similar host range and near identity of the 16S rRNA genes of
E. phagocytophila, E. equi, and the HGE agent
(7) have raised the possibility that these organisms
represent a single species (2, 28). In addition, Dumler et
al. (9) have shown that they share significant antigenicity
by immunofluorescence and immunoblot assays. Objective methods for
species classification, e.g., molecular genetic analysis, have not been
readily available, primarily because of an inability to culture these
ehrlichiae in vitro. However, we (reference 43 and
unpublished data) and others (13) have recently demonstrated
successful cultivation of GE isolates from dogs and humans,
respectively.
In this paper, we describe the use of purified GE obtained from in
vitro culture of infected HL60 cells, a promyelocytic human cell line,
to generate a genomic DNA library for expression screening with sera
obtained from dogs experimentally infected with GE. The screening
resulted in the isolation of recombinant clones containing complete
genes encoding three putative proteins of GE, GE 160, GE 130, and GE
100 (named for apparent molecular mass in kilodaltons). One of these
proteins, the 100-kDa protein, is similar in both glutamic acid content
and repeated amino acid structure to an immunodominant 120-kDa E. chaffeensis protein (45). Both the 100- and 130-kDa
granulocytic Ehrlichia proteins share some amino acid
sequence homology to the 120-kDa E. chaffeensis protein.
 |
MATERIALS AND METHODS |
Isolation of GE in cell culture.
The GE agent (strain USG3)
was isolated as described previously (43). Briefly, blood
from a dog experimentally infected by adult Ixodes
scapularis ticks collected from both Westchester County, N.Y., and
Montgomery County, Pa., was inoculated into a suspension culture of the
human promyelocytic cell line HL60 (ATCC CCL 240). The cells were
cultured in RPMI 1640 medium supplemented with 20% heat-inactivated
fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate,
and 0.1 mM nonessential amino acids and maintained at 37°C and 6%
CO2 in a humidified chamber. The fetal bovine serum was
reduced to 10% once the culture was established. Ehrlichial infection
was indicated by lysis of the HL60 cells. Cultures of USG3 (passages 7 to 21) were grown for 5 days prior to GE purification.
Purification of GE.
USG3 cultures at approximately 80% cell
lysis (monitored microscopically) were centrifuged at 840 × g for 15 min at 4°C to remove host HL60 cell debris. The
supernatant was filtered through a Poretics (Livermore, Calif.)
5-µm-pore-diameter polycarbonate membrane, 47 mm in diameter,
followed by a Poretics 3-µm-pore-diameter filter under negative
pressure. The USG3 filtrate was centrifuged at 9460 × g in a Sorvall centrifuge for 30 min at 4°C. Following centrifugation, the GE pellet was resuspended in 5 ml of 25 mM Tris (pH
8.0)-10 mM MgCl2-0.9% NaCl. DNase I (Life Technologies, Gaithersburg, Md.) was added to a final concentration of 9 µg per ml,
and the solution was incubated for 15 min at 37°C. Following incubation, the DNase was inactivated by the addition of 0.5 ml of 0.5 M EDTA, and the GE was pelleted at 14,000 × g in a
Sorvall centrifuge for 30 min at 4°C.
PCR amplification and cloning of GE 16S ribosomal DNA.
Universal eubacterial primers for the 16S rRNA gene (41)
were modified to include restriction enzyme recognition sites as follows: forward primer, 5' CTGCAGGTTTGATCCTGG 3'
(PstI site); reverse primer, 5'
GGATCCTACCTTGTTACGACTT 3' (BamHI site). These primers
(0.5 µM) were added to a 100-µl reaction mixture containing 1× PCR
buffer II (Perkin-Elmer Corp.); 1.5 mM MgCl2 (Perkin-Elmer Corp.); 200 µM (each) dATP, dGTP, dCTP, and dTTP; 2.5 U of Amplitaq DNA polymerase; and 20 µl of USG3 DNA. Amplification was performed under the following conditions: 35 cycles at 94°C for 1 min, 53°C for 1 min, and 72°C for 2 min, followed by a 72°C incubation for 10 min. The amplified 1,500-bp fragment was digested with PstI and BamHI and ligated to pUC19 linearized with the same
enzymes. The resulting clone, pUCHGE16S, was sequenced as described
below.
Construction of a GE genomic library.
Genomic DNA was
isolated from purified GE with the QIAamp Genomic DNA kit (Qiagen,
Chatsworth, Calif.) for library preparation (Stratagene, La Jolla,
Calif.). The DNA was mechanically sheared to a 4- to 10-kb size range
and ligated to EcoRI linkers. Linkered fragments were
ligated into the EcoRI site of Lambda Zap II, and the
library was amplified in Escherichia coli XL1-Blue MRF' to a
titer of 1010 PFU/ml.
Expression screening of the genomic library.
Bacteriophage
were plated with XL1-Blue MRF' and induced to express protein with 10 mM isopropyl-
-D-thiogalactopyranoside (IPTG) (Sigma, St.
Louis, Mo.). Proteins were transferred to nitrocellulose filters, and
the filters were washed with Tris-buffered saline (TBS; 25 mM Tris HCl
[pH 7.5], 0.5 M NaCl). Washed filters were blocked in TBS containing
0.1% polyoxyethylene 20 cetyl ether (Brij 58) and incubated with a
1:50 dilution of pooled sera (depleted of anti-E. coli
antibodies) taken from four dogs experimentally infected by exposure to
field-collected adult I. scapularis ticks (8).
The filters were washed and incubated with rabbit anti-dog horseradish
peroxidase-conjugated immunoglobulin (Ig) antibody, rewashed, and
developed with 4-chloronaphthol. Positive plaques were isolated,
replated, and screened again. Plasmid DNA containing the putative
recombinant clones was obtained by plasmid rescue (Stratagene).
DNA sequencing and sequence analysis.
DNA sequencing of
recombinant clones was performed by the primer walking method and with
an ABI 373A DNA sequencer (ACGT, Northbrook, Ill.; Lark Technologies,
Houston, Tex.; and Sequegen, Shrewsbury, Mass.). Sequences were
analyzed by the MacVector (Oxford Molecular Group) sequence analysis
program, version 6.0. The BLAST algorithm, D version 1.4 (19,
20), was used to search for homologous nucleic acid and protein
sequences available on the National Center for Biotechnology
Information (NCBI) server.
PCR analysis of USG3 and HL60 DNA.
PCR primer sets were
designed based on the sequences of each of the three GE clones and are
as follows: S2 (forward, 5'-GCGTCTCCAGAACCAG-3'; reverse,
5'-CCTATATAGCTTACCG-3'), S7 (forward,
5'-GATGTTGCTTCGGGTATGC-3'; reverse,
5'-CAGAGATTACTTCTTTTTGCGG-3'), and S22 (forward,
5'-CACGCCTTCTTCTAC-3'; reverse,
5'-CTCTGTTGCTATAGGGGC-3'). Each 50-µl reaction
mixture contained 0.5 µM each primer, 1× PCR Supermix (Life
Technologies, Gaithersburg, Md.) and either 100 ng of USG3 DNA, 100 ng
of HL60 DNA, or 200 ng of plasmid DNA. PCR amplification was performed under the following conditions: 94°C for 30 s, 55°C for
30 s, and 72°C for 1 min. After 30 cycles, a single 10-min
extension at 72°C was done. PCR products were analyzed on 4% Nusieve
3:1 agarose gels (FMC Bioproducts, Rockland, Me.).
Western blot analysis.
Individual recombinant
plasmid-containing cultures were induced to express protein with 5 mM
IPTG. Bacterial cells were pelleted by centrifugation and resuspended
in 5× Laemmli buffer (12% glycerol, 0.2 M Tris-HCl [pH 6.8], 5%
sodium dodecyl sulfate [SDS], 5%
-mercaptoethanol) at 200 µl
per optical density unit of culture. Samples were boiled for 5 min, and
10 µl of each was analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) (for dog sera) or NuPage (Novex, San Diego, Calif.)
electrophoresis (for human sera). Proteins were transferred to
nitrocellulose filters, the filters were blocked in TBS-Brij 58, and
the blots were probed with either the pooled dog sera referenced above
or 1:1,000 dilutions of human sera. The sera used in this study were
two convalescent-phase serum samples from patients (no. 2 and 3 from
New York, kindly provided by M. Aguero-Rosenfeld) and one sample from
an individual in Wisconsin who was part of a seroprevalence study (no.
1, kindly provided by J. Bakken). Blots were washed and incubated with
biotin-labeled goat anti-dog IgG (Kirkegaard & Perry Laboratories,
Inc., Gaithersburg, Md.) followed by peroxidase-labeled streptavidin
(Kirkegaard & Perry Laboratories, Inc.) or horseradish
peroxidase-conjugated antihuman IgG (Bio-Rad, Hercules, Calif.). After
several additional washes, the dog serum blots were developed with
4-chloronaphthol (Bio-Rad), and the human serum blots were detected by
enhanced chemiluminescence (Pierce, Rockford, Ill.) and viewed by
autoradiography.
Nucleotide sequence accession number.
The nucleotide
sequences of the GE genes described here have been assigned the
following GenBank accession numbers: ank (GE 160), AF020521;
rea (GE 130), AF020522; and gra (GE 100), AF020523.
 |
RESULTS |
Cloning and sequencing of the USG3 16S rRNA gene.
Sources of
GE used to generate a cell culture isolate have included blood from
either infected humans (13) or dogs (32, 43). To
assess the relatedness of the USG3 isolate to other GE isolates,
including the HGE agent, the 16S rRNA gene was amplified by PCR with
universal eubacterial primers (41). A 1,500-bp DNA fragment
was isolated and cloned into pUC19 (see Materials and Methods), and the
insert DNA was sequenced. The USG3 16S rRNA gene sequence was found to
be identical to the GenBank sequence of the HGE agent (accession no.
U02521). The sequences of other 16S ribosomal DNA PCR fragments
generated with USG3 DNA as the template were also identical to the HGE
agent sequence (reference 43 and data not shown).
Isolation of recombinant clones identified with GE-positive dog
sera.
Using pooled sera from adult I. scapularis-challenged, GE-infected dogs, positive clones were
identified and purified as single plaques. pBluescript plasmids were
rescued according to the Stratagene protocol, and DNA was purified with
Qiagen plasmid purification kits. A number of restriction digests were
performed with each clone to assess their relatedness (data not shown).
Based on these digests, restriction maps were generated which showed
that all of the clones represented just three different GE genes. One
clone from each of the three gene groups (clones S2, S7, and S22) was chosen for further analysis.
Analysis of proteins encoded by GE clones.
Because recombinant
clones were selected based on immunoreactivity, bacterial lysates of
each clone were analyzed by SDS-PAGE and Western blotting to identify
the immunoreactive proteins. The blots were probed with the same pooled
canine sera used to screen the library. Figure
1A shows the reactivity of the antisera against purified USG3. Several immunodominant proteins with sizes of
36, 43, and 45 kDa were observed, and other less-immunoreactive proteins of various molecular masses are shown. Figure 1B shows the
Western blot of the library clones, S2, S7, and S22. A single high-molecular-mass protein (indicated by arrows) was detected by the
sera for each isolated clone. These proteins were not expressed in the
absence of IPTG induction and were not detected with preimmune dog sera
(data not shown). The approximate molecular masses of each protein are
as follows: 160 (S2), 100 (S7), and 130 (S22) kDa. These proteins are
not the major immunodominant antigens of the purified cell culture
isolate USG3, two of which migrate at about 43 to 45 kDa (Fig. 1A), but
they could be present among the higher-molecular-mass immunoreactive
proteins.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Expression of GE proteins by Western blotting. (A)
Purified USG3 disrupted in SDS (lane GE). (B) Individual recombinant
clones containing the genes coding for GE 100, GE 160, GE 130, and a
negative control (NEG [no insert]) were grown and incubated with IPTG
to induce protein expression as described in Materials and Methods.
Samples of each were electrophoresed on SDS-PAGE gels and transferred
to nitrocellulose for Western blotting. Blots were probed with
convalescent-phase dog sera. Molecular mass markers (M) (in
kilodaltons) are shown to the left of each panel.
|
|
The three GE proteins were also analyzed by Western blotting for their
reactivity with human sera. Figure
2
shows three different
human serum samples tested against purified USG3
antigen and the
three GE recombinant proteins. Each serum sample
reacted strongly
with one of the three GE proteins: no. 1 with GE 160 and less
strongly with GE 130, no. 2 with GE 100, and no. 3 with GE
130.
All three serum samples reacted with several proteins in the
purified
USG3 lanes (GE lanes). A serum sample from a Rhode Island HGE
patient recognized two of the three GE proteins, and other HGE
patient
sera tested also recognized one or two of the proteins
(data not
shown). None of the samples we have tested to date react
strongly with
all three recombinant GE proteins. Negative control
human sera did not
react with the GE proteins on Western blots
(data not shown).

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of GE proteins by Western blotting. Three
different human serum samples were used to probe Western blots
containing SDS-disrupted USG3 (GE lanes), GE 160, GE 100, and GE 130. A
pBluescript library clone containing no insert was used as a negative
control (NEG). The origin of the sera is indicated at the bottom of
each panel (WI, Wis.; NY, N.Y.). Molecular mass markers (in
kilodaltons) are shown to the left of each panel.
|
|
It is interesting to note that these human sera do not strongly
recognize proteins with sizes of 100, 130, and 160 kDa with
USG3
lysates as the antigen source. This may be due to underrepresentation
of these proteins in the purified cell culture antigen, either
because
they are secreted or because they are expressed only after
infection of
a host species.
DNA sequencing and database analysis of recombinant clones.
The inserts from each of the recombinant plasmids S2, S7, and S22 were
completely sequenced by the primer walking method. Sequence analysis
(MacVector 6.0; Oxford Molecular Group) showed that each clone
contained a single large open reading frame encoded by the plus strand
of the insert and that each one appeared to be a complete gene. The
portions of the DNA sequence containing the open reading frame and
corresponding amino acid sequence of each of the clones are shown as
follows: Fig. 3, S2, GE 160; Fig. 4, S7, GE 100; and Fig.
5, S22, GE 130. A possible ribosome
binding site sequence upstream from the initiating ATG codon is
underlined in each figure.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 3.
Sequence of the 160-kDa protein gene. Nucleotide numbers
are indicated to the left. The ATG start codon and TAA stop codon are
shown in boldface type. The translated amino acid sequence for the open
reading frame is displayed underneath the DNA sequence according to the
single-letter amino acid code. Upstream regulatory sequences are
underlined and represent the 35, 10, and ribosome binding sites.
|
|

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 4.
Sequence of the 100-kDa protein gene. Nucleotide numbers
are indicated to the left. The ATG start codon and TAA stop codon are
shown in boldface type. The translated amino acid sequence for the open
reading frame is displayed underneath the DNA sequence according to the
single-letter amino acid code. A possible ribosome binding site is
underlined.
|
|

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 5.
Sequence of the 130-kDa protein gene. Nucleotide numbers
are indicated to the left. The ATG start codon and TAA stop codon are
shown in boldface type. The translated amino acid sequence for the open
reading frame is displayed underneath the DNA sequence according to the
single-letter amino acid code. A possible ribosome binding site is
underlined.
|
|
The numbers of nucleotides sequenced upstream of each reading frame
were 1,500 bp for the S2 insert, 500 bp for the S22 insert,
and 200 bp
for the S7 insert. These sequences were examined for
likely ehrlichial
promoter sequences based on homology to the
E. coli 
35 and

10 consensus sequences (
16). Of the three clones,
S2 had
the closest homology to the
E. coli promoter sequences,
and
these are underlined in Fig.
3. A number of possible promoter
sequences
were found for the S22 and S7 genes, but in the absence
of direct
experimental evidence, it is difficult to determine
which sequence
elements are necessary for promoter function. Protein
expression in all
three clones was IPTG dependent, and thus it
is likely that the vector
lacZ promoter is used for transcription
of the
Ehrlichia RNA in
E. coli.
Amino acid sequence analysis of the proteins encoded by the three gene
clones showed that all contain regions of repeated
amino acids. A
schematic version of these repeat structures is
shown in Fig.
6 and
7.
The 160-kDa protein (Fig.
6) has three
groups of repeats. The first set
consists of a number of ankyrin-like
repeat units of 33 amino acids,
the second consists of repeat
units of 27 amino acids, and the third
consists of repeat units
of 11 amino acids. The ankyrin repeats were
revealed by a BLAST
database search for protein homologies. Ankyrin
repeats occur
in at least four consecutive copies and are present in
yeast,
plants, bacteria, and mammals (
5,
6). Figure
6 shows
a multiple
alignment of the 160-kDa protein ankyrin repeats under a
consensus
sequence derived from the analysis of several hundred similar
ankyrin-like motifs (
6). The eighth repeat sequence holds to
the consensus only through the first half of the repeat unit and
may
not represent a full ankyrin-like repeat.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 6.
Schematic diagram of the GE 160-kDa protein. Repeat
regions are indicated by the boxes. Sequences of proposed ankyrin
repeats, numbered 1 to 8, are aligned according to the consensus
sequence at the top (6). h, hydrophobic; t, turn-like or
polar; S/T, serine or threonine; capital letters, conserved amino
acids.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 7.
Amino acid sequence alignments of selected regions of GE
130-kDa and E. chaffeensis 120-kDa proteins (A) and GE
100-kDa and E. chaffeensis 120-kDa proteins (B). Each
protein is shown as a linear amino acid sequence, and amino acids are
numbered in hundreds. Boxed regions on the linear sequence represent
repeated amino acids. (A) Amino acid alignments of a sequence which
occurs four times in the E. chaffeensis protein
(45) (top line of alignment, A-1) and eight times in the GE
130-kDa protein (a-1 to a-4). Sequence a-1 is repeated three times,
related sequences a-2 and a-3 are each repeated twice, and related
sequence a-4 is found once. The positions of these sequences in the
proteins are indicated by the small bold lines. (B) Alignments of two
different sequence motifs which occur in the E. chaffeensis
120-kDa protein (B-1 to B-3 and C-1) and the GE 100-kDa protein (b-1
and c-1). Bold and cross-hatched boxes indicate the positions of these
sequences in the proteins. Identical amino acids are surrounded by
boxes, and conserved amino acids are in capital letters.
|
|
The 130-kDa protein (Fig.
7) has a repeat unit of 26 to 34 amino acids
which occurs eight times in the carboxy-terminal half
of the protein.
The sequence varies somewhat from repeat to repeat.
A database homology
search with the NCBI BLAST algorithm revealed
that the 130-kDa protein
has limited homology to the
E. chaffeensis 120-kDa protein
(
45). An amino acid sequence alignment of a
motif common to
both proteins is shown in Fig.
7A. This motif
is represented by a bold
line and occurs four times in an identical
fashion in the
E. chaffeensis protein (designated A-1) and eight
times with four
variations in the GE 130-kDa protein (a-1, a-2,
a-3, and a-4).
The 100-kDa protein (Fig.
7) has three large repeat units, which differ
somewhat in length. A database search revealed that
it is similar to
the 120-kDa
E. chaffeensis protein, which contains
four
repeats of 80 amino acids each (
45). Both proteins contain
large amounts of glutamic acid: 18% for the 100-kDa protein and
17%
for the 120-kDa protein. When the two protein sequences are
aligned,
most of the homology occurs in the repeat regions. Figure
7B shows
alignments for two homologous groups of amino acid motifs
from the two
proteins (designated B/b and C/c) found with the
BLAST algorithm. These
are not the only possible alignments of
the two proteins but do provide
an example of their similarities.
The locations of the homologous
sequences are indicated by bold
or hatched lines above (GE 100) or
below (
E. chaffeensis 120)
the respective proteins. The B
sequence represented by the bold
line varies slightly in the
E. chaffeensis protein (shown as B-1,
B-2, and B-3) and occurs a
total of five times. The GE 100 protein
equivalent, b-1, is invariant
and occurs three times. The sequence
represented by the hatched line
occurs four times in
E. chaffeensis 120 (C-1) and two times
in GE 100 (c-1).
All of the GE proteins migrated at higher apparent molecular masses
under reducing conditions than calculations would predict.
The GE 160 protein consists of 748 amino acids with a calculated
molecular mass of
78.8 kDa. The GE 100 protein has 578 amino acids,
and its calculated
molecular mass is 61.4 kDa. The GE 130 protein
contains 619 amino acids
and has a calculated molecular mass of
66.1 kDa.
Verification that clones are GE derived with PCR analysis.
Based on the DNA sequences of each clone, PCR primers were designed to
amplify specific regions of each open reading frame (see Materials and
Methods). Primer pairs specific for S22, S2, and S7 were used in
separate PCRs to amplify three different templates: GE DNA (from USG3),
HL60 DNA, or the purified plasmid DNA of each clone. Figure
8 shows the results obtained for primers
of S2 (lanes 2 to 4), S7 (lanes 5 to 7), and S22 (lanes 8 to 10). All
three clones were specific to GE and were not present in HL60 DNA
(lanes 2, 5, and 8). In each case, the size of the PCR product
determined with genomic DNA as the template was the same as that
generated by the purified plasmid DNA.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 8.
PCR analysis of GE genes. PCRs were performed as
described in Materials and Methods, and the products were analyzed with
4% Nusieve gels. S2 primers were used to amplify a 395-bp region of S2
DNA with HL60 DNA (lane 2), S2 plasmid DNA (lane 3), and USG3 DNA (lane
4) used as templates. S7 primers were used to amplify a 643-bp region
of S7 DNA with HL60 DNA (lane 5), S7 plasmid DNA (lane 6), and USG3 DNA
(lane 7) used as templates. S22 primers were used to amplify a 159-bp
region of S22 DNA with HL60 DNA (lane 8), S22 plasmid DNA (lane 9), and
USG3 DNA (lane 10) used as templates. DNA molecular size markers (M)
(50 to 1,000 bp [FMC, Rockland, Maine]) are present in lane 1.
|
|
 |
DISCUSSION |
Ehrlichiae which have a tropism for peripheral blood granulocytes
and are closely related based on the sequence of the 16S rRNA gene have
been classified as either E. phagocytophila, E. equi, or the agent of HGE, depending on the species and
geographical location of the infected host. E. phagocytophila is responsible for a tick-borne fever of cattle,
sheep, and goats and occurs primarily in Europe (10, 33),
and E. equi is found in horses in North and South America
(14, 26). The agent of HGE has been identified as the
organism responsible for disease in patients in the upper midwestern
and northeastern United States (3, 7). However,
classification of GE has been difficult because of a lack of genetic
information.
The GE isolate we describe here is indistinguishable from the HGE agent
based on the sequence of the 16S rRNA gene. We also describe three
previously unidentified proteins of GE, the 160-, 130-, and 100-kDa
proteins. Aside from the 16S rRNA gene and the relatively conserved
groEL homolog (22), the genes coding for these
proteins are the first sequenced genes reported for this organism.
Using PCR primers based on the sequences of the three genes, we have
confirmed that the genes are specific for GE and that they are not
derived from the HL60 cell line used to culture the organism.
Preliminary results also show that these genes are present in other
members of the GE genogroup, including E. phagocytophila (31a).
The three GE proteins described in this study exhibit several
interesting features. All three of the proteins contain repeated regions of amino acids. In the 100-kDa protein, the repeats comprise the majority of the protein, with the exception of the amino terminus. The direct repeats in both the 160- and 130-kDa proteins occur in the
carboxyl half of the molecules. Various biological functions have been
demonstrated or implicated for repeat regions found in other proteins.
These include antigenic variation (17, 31) and ligand
interaction (11, 42), both of which are thought to occur in
several species of pathogenic bacteria (42). In several
proteins of the malaria parasite Plasmodium falciparum, repeated regions are often the major targets for the host antibody response (21). Proteins with several repeated domains are
also often found associated with the cell surface (12, 42).
In addition to the direct repeats, the 160-kDa protein contains seven to eight ankyrin-like repeats. These domains have been found in over 90 different proteins from nearly all phyla, including both E. coli and humans (6). They are present in functionally
diverse proteins, such as enzymes, toxins, and transcription factors, and are thought to play a role in protein-protein interactions (5). Human erythrocyte ankyrin contains 22 repeats, some of which may be involved in binding tubulin, spectrin, or vimentin. The
repeats could thus enable the protein to act like a bridge between
cytoskeleton and membrane components (23). The myriad functions ascribed to proteins containing repeated regions may imply
that the GE proteins described here will be found to have roles in host
cell binding, antigenic variation, or some other cell surface function.
The presence of repeated regions in the 100-, 130-, and 160-kDa
proteins may in part explain the differences between the expected molecular masses and the observed molecular masses on SDS-PAGE, which
are much higher. This phenomenon has been reported for other proteins
containing repeated regions, including rickettsial proteins (1,
36), malaria antigens (21), the fibronectin-binding protein from Staphylococcus aureus (18, 37), and
the E. chaffeensis 120-kDa protein (45). The
difference between calculated and observed molecular mass varies from
10 to 30% for the malaria antigens to almost 100% for the S. aureus and E. chaffeensis proteins. Investigators have
speculated that high percentages of certain amino acids in these
proteins or posttranslational modifications may contribute to the
aberrant migration in an SDS-polyacrylamide gel system (18, 37,
45).
A search of the major protein and nucleotide databases with the NCBI
BLAST algorithm did not reveal any significant similarities of the GE
proteins to any known proteins, other than the ankyrin repeats of the
160-kDa protein and the homology between the 100-kDa protein or 130-kDa
protein and the 120-kDa protein of E. chaffeensis. The
function of the E. chaffeensis 120-kDa protein is not known, but the hydrophilic nature of its repeat domain suggests that it may be
located on the surface of E. chaffeensis (45).
The GE 100-kDa protein is also hydrophilic in the repeat region (data not shown) and may also be surface associated. Although both the 100- and 130-kDa proteins have some homology to the E. chaffeensis 120-kDa protein, they are not homologous to one
another. It is possible that whatever the function(s) of the 120-kDa
protein is for E. chaffeensis, similar functions may be
carried out in GE through the proteins GE 100 and GE 130.
It is unclear whether the three GE proteins described in this report
may be useful as potential diagnostic reagents or vaccine candidates.
Although they are not well represented in the purified-culture-grown organism, either because they are secreted into the culture medium or
their expression is tied more closely to natural infection, they are
clearly important immunologically. All three react with convalescent-phase sera from dogs, sheep (data not shown), and humans
diagnosed with HGE. The E. chaffeensis 120-kDa protein, the
counterpart of the 100-kDa GE protein, has shown sensitivity and
specificity as a diagnostic reagent with a panel of E. chaffeensis patient sera (44). However, Western blots
with convalescent-phase sera from HGE patients do not show a consistent
response to the GE 100-kDa protein. It is not known whether there is
any immunologic cross-reactivity between the GE 100-kDa protein and the
E. chaffeensis 120-kDa protein or whether the two could be
used to distinguish monocytic from granulocytic ehrlichiosis. Some
human antisera have been reported to react with both E. chaffeensis and HGE antigens, but it is not known whether this
represents cross-reactive epitopes or separate exposures to the two
ehrlichial agents (30, 32).
In summary, the expression library approach for the isolation and
characterization of GE proteins has resulted in the discovery of three
previously unidentified genes which express high-molecular-weight, immunoreactive proteins. Further study of these proteins will aid in
the classification of the members of the GE genogroup as corresponding
genes are sequenced and compared and will be important in elucidating
the role of these proteins in immunity and pathogenesis.
 |
ACKNOWLEDGMENTS |
We thank Durland Fish (Yale University) for the experimental
challenge work with dogs which led to the isolation of GE in cell
culture and Johan Bakken and Maria Aguero-Rosenfeld for the kind gift
of human sera.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Aquila
Biopharmaceuticals, 365 Plantation St., Worcester, MA 01605. Phone:
(508) 797-5777, ext. 188. Fax: (508) 797-4014. E-mail:
molbio{at}splusnet.com.
Editor: P. E. Orndorff
 |
REFERENCES |
| 1.
|
Allred, D. R.,
T. C. McGuire,
G. H. Palmer,
S. R. Leib,
T. M. Harkins,
T. F. McElwain, and A. F. Barbet.
1990.
Molecular basis for surface antigen size polymorphisms and conservation of a neutralization-sensitive epitope in Anaplasma marginale.
Proc. Natl. Acad. Sci. USA
87:3220-3224[Abstract/Free Full Text].
|
| 2.
|
Anderson, B. E.,
J. E. Dawson,
D. C. Jones, and K. H. Wilson.
1991.
Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.
J. Clin. Microbiol.
29:2838-2842[Abstract/Free Full Text].
|
| 3.
|
Bakken, J. S.,
J. S. Dumler,
S.-M. Chen,
M. R. Eckman,
L. L. Van Etta, and D. H. Walker.
1994.
Human granulocytic ehrlichiosis in the upper Midwest. A new species emerging?
JAMA
272:212-218[Abstract/Free Full Text].
|
| 4.
|
Bakken, J. S.,
J. Krueth,
C. Wison-Nordskog,
R. L. Tilden,
K. Asanovich, and J. S. Dumler.
1996.
Clinical and laboratory characteristics of human granulocytic ehrlichiosis.
JAMA
275:199-205[Abstract/Free Full Text].
|
| 5.
|
Blank, V.,
P. Kourilsky, and A. Israel.
1992.
NF-kB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats.
Trends Biochem. Sci.
17:135-140[Medline].
|
| 6.
|
Bork, P.
1993.
Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally?
Proteins Struct. Funct. Genet.
17:363-374.
[Medline] |
| 7.
|
Chen, S.-M.,
J. S. Dumler,
J. S. Bakken, and D. H. Walker.
1994.
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.
J. Clin. Microbiol.
32:589-595[Abstract/Free Full Text].
|
| 8.
|
Coughlin, R. T.,
D. Fish,
T. N. Mather,
J. Ma,
C. Pavia, and P. Bulger.
1995.
Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, Osp B, and the saponin adjuvant QS-21.
J. Infect. Dis.
171:1049-1052[Medline].
|
| 9.
|
Dumler, J. S.,
K. M. Asanovich,
J. S. Bakken,
P. Richter,
R. Kimsey, and J. E. Madigan.
1995.
Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic ehrlichia.
J. Clin. Microbiol.
33:1098-1103[Abstract].
|
| 10.
|
Foggie, A.
1951.
Studies on the infectious agent of tick-borne fever in sheep.
J. Pathol. Bacteriol.
63:1-15.
|
| 11.
|
Gaillard, J.-L.,
P. Berche,
C. Frehel,
E. Gouin, and P. Cossart.
1991.
Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from Gram-positive cocci.
Cell
65:1127-1141[Medline].
|
| 12.
|
Gilmore, R. D.
1993.
Comparison of the rompA gene repeat regions of Rickettsiae reveals species-specific arrangements of individual repeating units.
Gene
125:97-102[Medline].
|
| 13.
|
Goodman, J. L.,
C. Nelson,
B. Vitale,
J. E. Madigan,
J. S. Dumler,
T. J. Kurtti, and U. G. Munderloh.
1996.
Direct cultivation of the causative agent of human granulocytic ehrlichiosis.
N. Engl. J. Med.
334:209-215[Abstract/Free Full Text].
|
| 14.
|
Gribble, D. H.
1969.
Equine ehrlichiosis.
J. Am. Vet. Med. Assoc.
155:462-469[Medline].
|
| 15.
|
Hardalo, C. J.,
V. Quagliarello, and J. S. Dumler.
1995.
Human granulocytic ehrlichiosis in Connecticut: report of a fatal case.
Clin. Infect. Dis.
21:910-914[Medline].
|
| 16.
|
Hawley, D. K., and W. R. McClure.
1983.
Compilation and analysis of Escherichia coli promoter DNA sequences.
Nucleic Acids Res.
11:2237-2255[Abstract/Free Full Text].
|
| 17.
|
Hoft, D. F.,
K. S. Kim,
K. Otsu,
D. R. Moser,
W. J. Yost,
J. H. Blumin,
J. E. Donelson, and L. V. Kirchhoff.
1989.
Trypanosoma cruzi expresses diverse repetitive protein antigens.
Infect. Immun.
57:1959-1967[Abstract/Free Full Text].
|
| 18.
|
Hollingshead, S. K.,
V. A. Fischetti, and J. R. Scott.
1986.
Complete nucleotide sequence of type 6M protein of the group A Streptococcus.
J. Biol. Chem.
261:1677-1686[Abstract/Free Full Text].
|
| 19.
|
Karlin, S., and S. F. Altschul.
1990.
Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes.
Proc. Natl. Acad. Sci. USA
87:2264-2268[Abstract/Free Full Text].
|
| 20.
|
Karlin, S., and S. F. Altschul.
1993.
Applications and statistics for multiple high scoring segments in molecular sequences.
Proc. Natl. Acad. Sci. USA
90:5873-5877[Abstract/Free Full Text].
|
| 21.
|
Kemp, D. J.,
R. L. Coppel, and R. F. Anders.
1987.
Repetitive proteins and genes of malaria.
Annu. Rev. Microbiol.
41:181-208[Medline].
|
| 22.
|
Kolbert, C. P.,
E. S. Bruinsma,
A. S. Abdulkarim,
E. K. Hofmeister,
R. B. Tompkins,
S. R. Telford III,
P. D. Mitchell,
J. Adams-Stich, and D. H. Persing.
1997.
Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis.
J. Clin. Microbiol.
35:1172-1178[Abstract].
|
| 23.
|
Lux, S. E.,
K. M. John, and V. Bennett.
1990.
Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins.
Nature (London)
344:36-42[Medline].
|
| 24.
|
Madewell, B. R., and D. H. Gribble.
1982.
Infection in two dogs with an agent resembling Ehrlichia equi.
J. Am. Vet. Med. Assoc.
180:512-514[Medline].
|
| 25.
|
Madigan, J. E., and D. H. Gribble.
1987.
Equine ehrlichiosis in northern California: 49 cases (1968-1981).
J. Am. Vet. Med. Assoc.
190:445-448[Medline].
|
| 26.
|
Madigan, J. E.,
S. Hietala,
S. Chalmers, and E. DeRock.
1990.
Seroepidemiologic survey of antibodies to Ehrlichia equi in horses of northern California.
J. Am. Vet. Med. Assoc.
196:1962-1964[Medline].
|
| 27.
|
Madigan, J. E.
1993.
Equine ehrlichiosis, p. 209-214. In
Z. Woldehiwet, and M. Ristic (ed.), Rickettsial and chlamydial diseases of domestic animals.
Pergamon Press, Oxford, United Kingdom.
|
| 28.
|
Madigan, J. E.,
P. J. Richter,
R. B. Kimsey,
J. E. Barlough,
J. S. Bakken, and J. S. Dumler.
1995.
Transmission and passage in horses of the agent of human granulocytic ehrlichiosis.
J. Infect. Dis.
172:1141-1144[Medline].
|
| 29.
|
Madigan, J. E.,
J. E. Barlough,
J. S. Dumler,
N. S. Schankman, and E. DeRock.
1996.
Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia.
J. Clin. Microbiol.
34:434-435[Abstract].
|
| 30.
|
Magnarelli, L. A.,
J. S. Dumler,
J. F. Anderson,
R. C. Johnson, and E. Fikrig.
1995.
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera.
J. Clin. Microbiol.
33:3054-3057[Abstract].
|
| 31.
|
Matsumoto, M.,
Y. Tange,
T. Okada,
Y. Inoue,
T. Horiuchi,
Y. Kobayashi, and S. Fujita.
1996.
Deletion in the 190 kDa antigen repeat region of Rickettsia rickettsii.
Microb. Pathog.
20:57-62[Medline].
|
| 31a.
| Murphy, C. I., et al. Unpublished observations.
|
| 32.
|
Nicholson, W. L.,
J. A. Comer,
J. W. Sumner,
C. Gingrich-Baker,
R. T. Coughlin,
L. A. Magnarelli,
J. G. Olson, and J. E. Childs.
1997.
An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis.
J. Clin. Microbiol.
35:1510-1516[Abstract].
|
| 33.
|
Rikihisa, Y.
1991.
The tribe Ehrlichiae and ehrlichial diseases.
Clin. Microbiol. Rev.
4:286-308[Abstract/Free Full Text].
|
| 34.
|
Rikihisa, Y.,
S. A. Ewing,
J. C. Fox,
A. G. Siregar,
F. H. Pasaribu, and M. B. Malole.
1992.
Analyses of Ehrlichia canis and a canine granulocytic Ehrlichia infection.
J. Clin. Microbiol.
30:143-148[Abstract/Free Full Text].
|
| 35.
|
Rodgers, S. J.,
R. J. Morton, and C. A. Baldwin.
1989.
A serological survey of Ehrlichia canis, Ehrlichia equi, Rickettsia rickettsii, and Borrelia burgdorferi in dogs in Oklahoma.
J. Vet. Diagn. Invest.
1:154-159[Abstract/Free Full Text].
|
| 36.
|
Schuenke, K. W., and D. H. Walker.
1994.
Cloning, sequencing, and expression of the gene coding for an antigenic 120-kilodalton protein of Rickettsia conorii.
Infect. Immun.
62:904-909[Abstract/Free Full Text].
|
| 37.
|
Signas, C.,
G. Raucci,
K. Jonsson,
P. Lindgren,
G. M. Anantharamaiah,
M. Hook, and M. Lindberg.
1989.
Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.
Proc. Natl. Acad. Sci. USA
86:699-703[Abstract/Free Full Text].
|
| 38.
|
Stannard, A. A.,
D. H. Gribble, and R. S. Smith.
1969.
Equine ehrlichiosis: a disease with similarities to tick-borne fever and bovine petechial fever.
Vet. Rec.
84:149-150[Medline].
|
| 39.
|
Telford, S. R., III,
J. E. Dawson,
P. Katavolos,
C. K. Warner,
C. P. Kolbert, and D. H. Persing.
1996.
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.
Proc. Natl. Acad. Sci. USA
93:6209-6214[Abstract/Free Full Text].
|
| 40.
|
Walls, J. J.,
B. Greig,
D. F. Neitzel, and J. S. Dumler.
1997.
Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis.
J. Clin. Microbiol.
35:853-855[Abstract].
|
| 41.
|
Wilson, K. H.,
R. B. Blitchington, and R. C. Greene.
1990.
Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction.
J. Clin. Microbiol.
28:1942-1946[Abstract/Free Full Text].
|
| 42.
|
Wren, B. W.
1991.
A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences.
Mol. Microbiol.
5:797-803[Medline].
|
| 43.
|
Yeh, M.-T.,
T. N. Mather,
R. T. Coughlin,
C. Gingrich-Baker,
J. W. Sumner, and R. F. Massung.
1997.
Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island.
J. Clin. Microbiol.
35:944-947[Abstract].
|
| 44.
|
Yu, X.-J.,
P. Crocquet-Valdes,
L. C. Cullman, and D. H. Walker.
1996.
The recombinant 120-kilodalton protein of Ehrlichia chaffeensis, a potential diagnostic tool.
J. Clin. Microbiol.
34:2853-2855[Abstract].
|
| 45.
|
Yu, X.-J.,
P. Crocquet-Valdes, and D. H. Walker.
1997.
Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis.
Gene
184:149-154[Medline].
|
Infect Immun, April 1998, p. 1356-1363, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ge, Y., Rikihisa, Y.
(2007). Identification of Novel Surface Proteins of Anaplasma phagocytophilum by Affinity Purification and Proteomics. J. Bacteriol.
189: 7819-7828
[Abstract]
[Full Text]
-
von Loewenich, F. D., Baumgarten, B. U., Schroppel, K., Geissdorfer, W., Rollinghoff, M., Bogdan, C.
(2003). High Diversity of ankA Sequences of Anaplasma phagocytophilum among Ixodes ricinus Ticks in Germany. J. Clin. Microbiol.
41: 5033-5040
[Abstract]
[Full Text]
-
Massung, R. F., Slater, K. G.
(2003). Comparison of PCR Assays for Detection of the Agent of Human Granulocytic Ehrlichiosis, Anaplasma phagocytophilum. J. Clin. Microbiol.
41: 717-722
[Abstract]
[Full Text]
-
Brown, W. C., McGuire, T. C., Mwangi, W., Kegerreis, K. A., Macmillan, H., Lewin, H. A., Palmer, G. H.
(2002). Major Histocompatibility Complex Class II DR-Restricted Memory CD4+ T Lymphocytes Recognize Conserved Immunodominant Epitopes of Anaplasma marginale Major Surface Protein 1a. Infect. Immun.
70: 5521-5532
[Abstract]
[Full Text]
-
Bjoersdorff, A., Bagert, B., Massung, R. F., Gusa, A., Eliasson, I.
(2002). Isolation and Characterization of Two European Strains of Ehrlichia phagocytophila of Equine Origin. CVI
9: 341-343
[Abstract]
[Full Text]
-
Brown, W. C., Palmer, G. H., Lewin, H. A., McGuire, T. C.
(2001). CD4+ T Lymphocytes from Calves Immunized with Anaplasma marginale Major Surface Protein 1 (MSP1), a Heteromeric Complex of MSP1a and MSP1b, Preferentially Recognize the MSP1a Carboxyl Terminus That Is Conserved among Strains. Infect. Immun.
69: 6853-6862
[Abstract]
[Full Text]
-
Lodes, M. J., Mohamath, R., Reynolds, L. D., McNeill, P., Kolbert, C. P., Bruinsma, E. S., Benson, D. R., Hofmeister, E., Reed, S. G., Houghton, R. L., Persing, D. H.
(2001). Serodiagnosis of Human Granulocytic Ehrlichiosis by Using Novel Combinations of Immunoreactive Recombinant Proteins. J. Clin. Microbiol.
39: 2466-2476
[Abstract]
[Full Text]
-
Caturegli, P., Asanovich, K. M., Walls, J. J., Bakken, J. S., Madigan, J. E., Popov, V. L., Dumler, J. S.
(2000). ankA: an Ehrlichia phagocytophila Group Gene Encoding a Cytoplasmic Protein Antigen with Ankyrin Repeats. Infect. Immun.
68: 5277-5283
[Abstract]
[Full Text]
-
Massung, R. F., Owens, J. H., Ross, D., Reed, K. D., Petrovec, M., Bjoersdorff, A., Coughlin, R. T., Beltz, G. A., Murphy, C. I.
(2000). Sequence Analysis of the ank Gene of Granulocytic Ehrlichiae. J. Clin. Microbiol.
38: 2917-2922
[Abstract]
[Full Text]
-
McBride, J. W., Yu, X.-j., Walker, D. H.
(2000). Glycosylation of Homologous Immunodominant Proteins of Ehrlichia chaffeensis and Ehrlichia canis. Infect. Immun.
68: 13-18
[Abstract]
[Full Text]
-
Walls, J. J., Caturegli, P., Bakken, J. S., Asanovich, K. M., Dumler, J. S.
(2000). Improved Sensitivity of PCR for Diagnosis of Human Granulocytic Ehrlichiosis Using epank1 Genes of Ehrlichia phagocytophila-Group Ehrlichiae. J. Clin. Microbiol.
38: 354-356
[Abstract]
[Full Text]
-
Yu, X.-j., McBride, J. W., Diaz, C. M., Walker, D. H.
(2000). Molecular Cloning and Characterization of the 120-Kilodalton Protein Gene of Ehrlichia canis and Application of the Recombinant 120-Kilodalton Protein for Serodiagnosis of Canine Ehrlichiosis. J. Clin. Microbiol.
38: 369-374
[Abstract]
[Full Text]
-
Ijdo, J. W., Wu, C., Magnarelli, L. A., Fikrig, E.
(1999). Serodiagnosis of Human Granulocytic Ehrlichiosis by a Recombinant HGE-44-Based Enzyme-Linked Immunosorbent Assay. J. Clin. Microbiol.
37: 3540-3544
[Abstract]
[Full Text]
-
Walls, J. J., Aguero-Rosenfeld, M., Bakken, J. S., Goodman, J. L., Hossain, D., Johnson, R. C., Dumler, J. S.
(1999). Inter- and Intralaboratory Comparison of Ehrlichia equi and Human Granulocytic Ehrlichiosis (HGE) Agent Strains for Serodiagnosis of HGE by the Immunofluorescent-Antibody Test. J. Clin. Microbiol.
37: 2968-2973
[Abstract]
[Full Text]
-
Murphy, C. I., Storey, J. R., Recchia, J., Doros-Richert, L. A., Gingrich-Baker, C., Munroe, K., Bakken, J. S., Coughlin, R. T., Beltz, G. A.
(1998). Major Antigenic Proteins of the Agent of Human Granulocytic Ehrlichiosis Are Encoded by Members of a Multigene Family. Infect. Immun.
66: 3711-3718
[Abstract]
[Full Text]